Perthera Funding: How Much Did They Raise & Key Investors

How Much Did Perthera Raise?
Funding & Key Investors

Perthera, a prominent player in the precision oncology sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $11.5M. This latest infusion of $393K underscores the firm's critical role in advancing AI-driven clinical decision support systems. By leveraging sophisticated data integration, the company continues to solidify its market position as a vital partner for oncology centers across the United States.

The company's financial trajectory, marked by a series of private equity and debt financing rounds, reflects a sustained commitment to scaling its proprietary analytics platform. As the healthcare industry increasingly pivots toward personalized medicine, Perthera's ability to synthesize complex molecular and clinical data into actionable insights has attracted significant institutional backing, positioning the firm for continued expansion in the competitive health-tech landscape.

What is Perthera?

Perthera

Software

Healthcare Software

Business Services

Founded in 2012, Perthera operates at the intersection of artificial intelligence and oncology. The company provides a robust AI-driven analytics solution that is currently deployed across more than 250 cancer treatment centers nationwide. By integrating a patient's comprehensive medical, treatment, and molecular profiles, Perthera's platform enables oncologists to identify highly tailored therapy options and relevant clinical trials. This data-centric approach is designed to enhance both overall and progression-free survival outcomes, effectively bridging the gap between complex genomic research and bedside clinical application.

How much funding has Perthera raised?

Perthera has raised a total of $11.5M across 5 funding rounds:

2014

Private Equity

$1.3M

2016

Series A

$8.7M

2017

Private Equity

$750K

2020

Debt

$350K

2021

Debt

$393K

Private Equity (2014): $1.3M, investors not publicly disclosed

Series A (2016): $8.7M led by Pilot Growth

Private Equity (2017): $750K supported by Pilot Growth Equity Partners

Debt (2020): $350K featuring PPP

Debt (2021): $393K backed by PPP

Key Investors in Perthera

Pilot Growth

A growth-oriented investment firm that focuses on scaling technology-enabled companies by providing strategic guidance and operational expertise.

Pilot Growth Equity Partners

A specialized venture capital entity that partners with high-growth technology firms to drive market leadership and sustainable long-term value.

PPP

Public-Private Partnership

What's next for Perthera?

With the recent influx of capital, Perthera is well-positioned to accelerate the deployment of its AI Insights platform and deepen its integration within the broader oncology ecosystem. The strategic focus will likely center on expanding the reach of its analytics engine to additional clinical sites and enhancing the platform's predictive capabilities. As the firm matures, the emphasis will remain on scaling its technological infrastructure to meet the growing demand for precision medicine, ensuring that oncologists have the most advanced tools available to navigate the rapidly evolving landscape of cancer care.

See full Perthera company page

See More Financial Insights